Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new study suggests that not having any maths education after the age of 16 can be disadvantageous.

Line of dice with mathematical symbols

Adolescents who stopped studying maths exhibited greater disadvantage – compared with peers who continued studying maths – in terms of brain and cognitive development, according to a new study published in the Proceedings of the National Academy of Sciences.

133 students between the ages of 14-18 took part in an experiment run by researchers from the Department of Experimental Psychology. Unlike the majority of countries worldwide, in the UK 16-year-old students can decide to stop their maths education. This situation allowed the team to examine whether this specific lack of maths education in students coming from a similar environment could impact brain development and cognition.

The study found that students who didn’t study maths had a lower amount of a crucial chemical for brain plasticity (gamma-Aminobutyric acid) in a key brain region involved in many important cognitive functions, including reasoning, problem solving, maths, memory and learning. Based on the amount of brain chemical found in each student, researchers were able to discriminate between adolescents who studied or did not study maths, independent of their cognitive abilities. Moreover, the amount of this brain chemical successfully predicted changes in mathematical attainment score around 19 months later. Notably, the researchers did not find differences in the brain chemical before the adolescents stopped studying maths.

Read the full story on the Department of Experimental Psychology website

The story is also featured on the University of Oxford website

Similar stories

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.